Fennec Pharmaceuticals (NASDAQ:FENC) shares climbed more than 3% in premarket trading on Thursday after the company reported first-quarter results that exceeded analyst expectations, supported by ...

Fennec Pharmaceuticals (NASDAQ:FENC) executives outlined the company’s commercial strategy for PEDMARK, its sodium ...

The latest price target for Fennec Pharmaceuticals (NASDAQ:FENC) was reported by HC Wainwright & Co. on August 21, 2025. The analyst firm set a price target for $13.00 expecting FENC to rise to within ...

Southpoint Capital Advisors LP, a ten-percent owner of Fennec Pharmaceuticals Inc (NASDAQ:FENC), reported selling 246,018 shares of common stock for approximately $2,035,625. The sales occurred in two ...

View Fennec Pharmaceuticals Inc. FENC stock quote prices, financial information, real-time forecasts, and company news from CNN.

Southpoint Capital Advisors LP, a ten percent owner of Fennec Pharmaceuticals Inc (NASDAQ:FENC), reported selling 19,341 shares of common stock on November 18, 2025. The shares were sold at prices ...